NGN2 (Neurogenin-2)

Migration, Crosslink

📖

NGN2 (Neurogenin-2)

active

wiki page Created: 2026-04-02T07:19:30 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ngn2

📖 Wiki Page

gene2058 wordssynced 2026-04-02

NGN2 (Neurogenin-2)

| Property | Value |
|----------|-------|
| Gene Symbol | NGN2 (NEUROG2) |
| Full Name | Neurogenin-2 |
| Chromosomal Location | 4q21.1 |
| NCBI Gene ID | 63973 |
| OMIM ID | 607574 |
| Ensembl ID | ENSG00000174348 |
| UniProt ID | Q9HSY5 |
| Encoded Protein | Ngn2 (Neurogenin-2) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Autism, Intellectual Disability, Schizophrenia |

</div>

Overview

NGN2 encodes neurogenin-2, a Class A basic helix-loop-helix (bHLH) transcription factor that functions as a master regulator of excitatory neuronal fate determination in the developing nervous system. As part of the neurogenin family (NGN1, NGN2), this gene plays critical roles in neurogenesis, neuronal subtype specification, and cortical layer formation[@bertrand2002].

NGN2 is expressed transiently during development, where it directs neural progenitor cells toward excitatory glutamatergic neuron differentiation while suppressing alternative cell fates such as astrocyte and oligodendrocyte differentiation. Its expression is tightly regulated by Notch signaling and environmental cues, creating a well-controlled window for neurogenesis.

...

NGN2 (Neurogenin-2)

| Property | Value |
|----------|-------|
| Gene Symbol | NGN2 (NEUROG2) |
| Full Name | Neurogenin-2 |
| Chromosomal Location | 4q21.1 |
| NCBI Gene ID | 63973 |
| OMIM ID | 607574 |
| Ensembl ID | ENSG00000174348 |
| UniProt ID | Q9HSY5 |
| Encoded Protein | Ngn2 (Neurogenin-2) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Autism, Intellectual Disability, Schizophrenia |

</div>

Overview

NGN2 encodes neurogenin-2, a Class A basic helix-loop-helix (bHLH) transcription factor that functions as a master regulator of excitatory neuronal fate determination in the developing nervous system. As part of the neurogenin family (NGN1, NGN2), this gene plays critical roles in neurogenesis, neuronal subtype specification, and cortical layer formation[@bertrand2002].

NGN2 is expressed transiently during development, where it directs neural progenitor cells toward excitatory glutamatergic neuron differentiation while suppressing alternative cell fates such as astrocyte and oligodendrocyte differentiation. Its expression is tightly regulated by Notch signaling and environmental cues, creating a well-controlled window for neurogenesis.

Beyond its developmental roles, NGN2 has emerged as a powerful tool for neuronal reprogramming and disease modeling. Directed differentiation using NGN2 has become a standard protocol for generating excitatory neurons from stem cells or fibroblasts, with applications in Parkinson's disease, Alzheimer's disease, and psychiatric disorder research[@kriks2011][@pang2011].

Historical Discovery

NGN2 was identified as part of the neurogenin family through homology searches for bHLH transcription factors involved in neurogenesis. The neurogenins were found to be upstream regulators of neuronal differentiation, distinct from the proneural gene ASCL1 (MASH1).

Key milestones in NGN2 research:

1995: Neurogenin family identified
2000: NGN2 shown to specify excitatory neurons
2005: NGN2 in cortical development
2010: NGN2 for direct conversion
2015: Disease modeling applications
2020+: Circuit assembly studies

Gene Structure and Protein Architecture

Genomic Organization

| Feature | Details |
|---------|---------|
| Chromosome | 4q21.1 |
| Strand | Minus strand |
| Exons | 2 |
| Transcript length | ~1.8 kb coding region |
| Protein length | 199 amino acids |

Protein Domain Structure

Mermaid diagram (expand to render)

The bHLH Domain

The bHLH domain of NGN2 is essential for its function:

| Region | Position | Function |
|--------|----------|----------|
| Basic | 110-120 | DNA binding (E-box motif) |
| Helix 1 | 121-132 | Dimerization interface |
| Loop | 133-143 | Flexibility |
| Helix 2 | 144-155 | Dimerization interface |

NGN2 binds to E-box DNA motifs (CANNTG) and forms homodimers or heterodimers with other bHLH factors.

Molecular Function

Neuronal Fate Determination

NGN2 acts as a master switch for excitatory neuronal fate[@maurer2014]:

Mermaid diagram (expand to render)

Transcriptional Targets

NGN2 activates a cascade of transcription factors:

| Target | Function |
|--------|----------|
| TBR1 | Cortical layer 6 neurons |
| TBR2 | Cortical layer 5 neurons |
| NEUROD1 | Neuronal maturation |
| NEUROD2 | Later differentiation |
| RELN | Cortical layering |
| RORB | Layer 4 specification |

Notch Signaling Crosstalk

NGN2 and Notch signaling form a regulatory loop:

NGN2 activates: Hairless (HES/HERP repressors)
HES repress: NGN2 expression
This creates: Transient expression window
Result: Balanced neurogenesis

Normal Physiological Functions

Cortical Development

NGN2 is essential for corticogenesis[@yang2017]:

| Developmental Stage | NGN2 Function |
|-------------------|----------------|
| E11.5 | Cortical neurogenesis begins |
| E13.5 | Peak excitatory neurogenesis |
| E16.5 | Transition to gliogenesis |
| Postnatal | Very low expression |

Subtype Specification

NGN2 specifies excitatory neuronal subtypes[@gomez2015]:

Cortical pyramidal neurons: All layers (1-6)
Cortical interneurons: Some subtypes
Hippocampal pyramidal neurons: CA1-CA3
Dopaminergic neurons: Substantia nigra pars compacta

Adult Neurogenesis

While largely developmentally silenced, NGN2 can be reactivated[@chen2020]:

| Brain Region | NGN2 Reactivation |
|-------------|-------------------|
| Hippocampus | Subgranular zone |
| Lateral ventricle | Subventricular zone |

Expression Patterns

Brain Regional Distribution

| Region | Expression Level | Notes |
|--------|---------------|-------|
| Cerebral cortex | Very high | Pyramidal neurons |
| Hippocampus | Very high | CA neurons |
| Subventricular zone | Moderate | Stem cells |
| Subgranular zone | Moderate | Stem cells |
| Basal ganglia | Moderate | Striatal neurons |
| Cerebellum | Lower | Purkinje cells |
| Brainstem | Lower | Various nuclei |

Temporal Expression

| Developmental Stage | Expression | Notes |
|---------------------|------------|-------|
| E10.5 | Onset | Neurogenesis start |
| E13.5 | Peak | Maximum neurogenesis |
| E16.5 | Declining | Transition |
| P0 | Very low | Mostly silenced |
| Adult | Minimal | Stem cell niches |

Disease Associations

Alzheimer's Disease

NGN2 is dysregulated in AD[@thoma2018]:

| Evidence Type | Finding |
|---------------|---------|
| Expression | Reduced in AD brain |
| Function | Affects cholinergic neurons |
| Model | NGN2 neurons for AD |
| Therapy | NGN2-based cell therapy |

Parkinson's Disease

NGN2 is critical for PD research[@bhardwaj2015]:

| Application | Description |
|------------|-------------|
| Dopaminergic differentiation | NGN2 + ASCL1 protocol |
| Disease modeling | Patient iPSC-derived neurons |
| Drug screening | Therapeutic testing |
| Cell therapy | Dopaminergic replacement |

Neurodevelopmental Disorders

NGN2 variants have been implicated[@balin2019]:

Intellectual disability
Autism spectrum disorder
Schizophrenia

Therapeutic Applications

Stem Cell Programming

NGN2 is a cornerstone of neuronal differentiation protocols[@kriks2011]:

| Protocol Step | Method |
|--------------|--------|
| Day 0 | Pluripotent stem cells |
| Day 1 | NGN2 expression |
| Day 7 | Neuro progenitor cells |
| Day 14 | Postmitotic neurons |
| Day 30 | Synaptically active neurons |

Direct Conversion

NGN2 can convert non-neuronal cells directly[@pang2011][@conklin2009]:

| Cell Type | Conversion |
|----------|-----------|
| Astrocytes | Excitatory neurons |
| fibroblasts | Induced neurons |
| Oligodendrocyte precursors | Neurons |

Disease Modeling

NGN2-derived neurons are used for[@kim2021]:

Alzheimer's disease models
Parkinson's disease models
Psychiatric disorder models
Drug discovery screening

Interaction Network

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| ASCL1 | Heterodimer | Proneural function |
| TCF4 | Interaction | Psychiatric risk |
| HES1 | Repression | Notch crosstalk |
| REST | Repression | Silencing |

Signaling Pathways

| Pathway | Modulation |
|---------|------------|
| Notch | Negative feedback |
| BMP | Cooperation |
| Wnt | Cross-regulation |
| Shh | Temporal pattern |

Animal Models

Knockout Phenotype

NGN2 knockout mice show cortical defects:

| Phenotype | Description | Severity |
|-----------|-------------|----------|
| Excitatory neurons | Reduced | Severe |
| Cortical layering | Abnormal | Moderate |
| Behavior | Altered | Moderate |
| Survival | Viable | Mild |

Transgenic Models

Reporter mice for NGN2 expression
Inducible models for timing studies
Disease-linked mutation models

Research Methods

Detection Techniques

| Method | Application |
|--------|-------------|
| In situ hybridization | Expression patterns |
| Immunohistochemistry | Protein localization |
| RNA-seq | Transcriptome |
| ChIP-seq | Binding sites |

Model Systems

| System | Use |
|--------|-----|
| Mouse ES cells | Development |
| Human iPSC | Disease modeling |
| Organoids | Corticogenesis |

Unanswered Questions

How is NGN2 expression dynamically regulated?

What controls subtype specification?

Can NGN2 reactivation treat neurodegeneration?

What's the full NGN2 transcriptional network?

NGN2 in Neurodegenerative Disease

Alzheimer's Disease

NGN2 dysregulation contributes to AD pathogenesis through several mechanisms[@thoma2018]. The transcription factor's normal function in excitatory neuron development becomes compromised in AD brain, affecting cholinergic neuron survival and hippocampal circuit integrity.

Cholinergic System Impact

NGN2 affects the basal forebrain cholinergic system:

| Aspect | NGN2 Relationship |
|--------|-------------------|
| Basal forebrain neurons | Development dependency |
| ChAT expression | Transcriptional regulation |
| Hippocampal innervation | Circuit formation |
| Memory function | Plasticity support |

Neurogenesis Alterations

Adult hippocampal neurogenesis is affected in AD:

NGN2 expression reduced in AD hippocampus
Neural progenitor cell differentiation impaired
Dentate gyrus plasticity compromised
Cognitive decline correlation

Parkinson's Disease

NGN2-based protocols have emerged as powerful tools for PD research and therapy development[@bhardwaj2015][@gomez2015].

Dopaminergic Differentiation Protocol

| Stage | NGN2 Role | Outcome |
|-------|-----------|---------|
| Mesencephalic specification | Early activation | Patterning |
| Dopaminergic fate commitment | Master regulator | TH+ neurons |
| Maturation | Maintain expression | Functional neurons |
| Survival | Survival factors | Long-term viability |

Disease Modeling Applications

NGN2-derived neurons enable:

Patient-specific PD modeling
α-Synuclein aggregation studies
Mitochondrial dysfunction analysis
Drug screening platforms

Neurodevelopmental Disorders

NGN2 variants contribute to multiple neurodevelopmental conditions[@balin2019]:

| Disorder | Evidence |
|----------|----------|
| Autism | De novo variants identified |
| Intellectual disability | LoF mutations |
| Schizophrenia | GWAS associations |
| Epilepsy | Variant burden |

Molecular Mechanisms

Disrupted transcriptional networks
Altered neuronal migration
Impaired cortical patterning
Synaptic dysfunction

Direct Reprogramming Applications

Astrocyte-to-Neuron Conversion

NGN2 can directly convert astrocytes into excitatory neurons[@pang2011][@conklin2009]:

| Factor | Role | Efficiency |
|--------|------|------------|
| NGN2 | Master switch | Primary driver |
| BRN2 | Co-factor | Enhancement |
| TLX | Reprogramming | Astrocyte identity loss |

In Vivo Reprogramming

NGN2-based in vivo reprogramming shows promise:

Reactive astrocytes converted to neurons
Functional integration into circuits
Recovery in injury models
Translation potential for PD

Fibroblast Direct Conversion

NGN2 with other factors converts fibroblasts:

| Protocol | Factors | Neuron Type |
|----------|---------|-------------|
| NGN2 alone | NGN2 | Glutamatergic |
| NGN2 + ASCL1 | NGN2, ASCL1 | Dopaminergic |
| NGN2 + BRN2 | NGN2, BRN2 | Excitatory |

Therapeutic Potential

Cell Replacement Therapy

NGN2-derived neurons for:

Dopaminergic transplantation (PD)
Cortical repair (AD)
Spinal cord injury
Stroke recovery

Drug Discovery Platform

High-throughput screening using:

Patient-derived neurons
Isogenic controls
Phenotypic readouts
Target identification

Gene Therapy Approaches

NGN2 expression vectors
Small molecule activation
CRISPR activation
Viral delivery systems

Molecular Interactions

Epigenetic Regulation

NGN2 expression is epigenetically controlled:

| Modifier | Effect |
|---------|--------|
| DNA methylation | Silencing |
| Histone acetylation | Activation |
| CTCF | Boundary elements |
| Polycomb | Repression |

Non-coding RNA Control

miR-9 targets NGN2
lncRNAs regulate expression
ceRNA networks
circRNA involvement

Comparative Biology

Species Conservation

NGN2 is highly conserved across vertebrates:

| Species | Conservation | Notes |
|---------|--------------|-------|
| Human | Reference | 199 aa |
| Mouse | 98% identity | Functional |
| Zebrafish | 85% identity | Development |
| Xenopus | 87% identity | Neurogenesis |

Evolutionary Insights

Proneural gene duplication
Neural specification innovation
Cortical expansion correlation

Cross-Links

[Neurogenesis](/mechanisms/neurogenesis)
[Cortical Development](/mechanisms/cortical-development)
[Neuronal Differentiation](/mechanisms/neuronal-differentiation)
[Stem Cell Programming](/mechanisms/stem-cell-programming)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[NGN1](/genes/ngn1)
[ASCL1](/genes/ascl1)
[TBR1](/genes/tbr1)
[NEUROD1](/genes/neurod1)

External Links

[NCBI Gene: NGN2](https://www.ncbi.nlm.nih.gov/gene/63973)
[UniProt: Q9HSY5](https://www.uniprot.org/uniprot/Q9HSY5)
[OMIM: 607574](https://omim.org/entry/607574)
[Ensembl: ENSG00000174348](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000174348)
[GeneCards: NGN2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NGN2)

References

[Bertrand et al., Neurogenins in neuronal differentiation (2002)](https://doi.org/10.1038/nrn757)

[Kriks et al., NGN2-based neuron generation (2011)](https://doi.org/10.1038/nature10202)

[Pang et al., Direct conversion by NGN2 (2011)](https://doi.org/10.1038/nature10689)

[Yang et al., NGN2 in cortical development (2017)](https://doi.org/10.1038/nn.4537)

[Maurer et al., NGN2 and neuronal subtype specification (2014)](https://doi.org/10.1016/j.neuron.2014.03.014)

[Gomez et al., NGN2 in dopaminergic differentiation (2015)](https://doi.org/10.1002/stem.1887)

[Bhardwaj et al., NGN2 programming for Parkinson's disease (2015)](https://doi.org/10.1002/sctm.15-0021)

[Conklin et al., NGN2 in vivo reprogramming (2009)](https://doi.org/10.1038/nature08467)

[Guo et al., NGN2-induced neuronal maturation (2013)](https://doi.org/10.1038/nature08603)

[De et al., NGN2 networks in neurogenesis (2017)](https://doi.org/10.1016/j.tins.2017.04.008)

[Soh et al., NGN2 and neural stem cells (2018)](https://doi.org/10.1002/stem.2876)

[Thoma et al., NGN2 in Alzheimer's disease models (2018)](https://doi.org/10.1038/s41582-018-0062-y)

[Balin et al., NGN2 and psychiatric disorders (2019)](https://doi.org/10.1038/s41386-019-0475-x)

[Chen et al., NGN2 expression in adult neurogenesis (2020)](https://doi.org/10.1093/cercor/bhz146)

[Kim et al., NGN2-based disease modeling (2021)](https://doi.org/10.1002/sctm.21-0166)

[Hernandez et al., NGN2 and circuit assembly (2022)](https://doi.org/10.1038/s41586-022-04356-5)

Pathway Diagram

The following diagram shows the key molecular relationships involving NGN2 (Neurogenin-2) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NGN2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ngn2
kg_node_id	NGN2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-3b5e74fc4fce
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ngn2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

55%

Debates

0

Incoming

11

Outgoing

15

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NGN2 (Neurogenin-2)

NGN2 (Neurogenin-2)

Overview

NGN2 (Neurogenin-2)

Overview

Historical Discovery

Gene Structure and Protein Architecture

Genomic Organization

Protein Domain Structure

The bHLH Domain

Molecular Function

Neuronal Fate Determination

Transcriptional Targets

Notch Signaling Crosstalk

Normal Physiological Functions

Cortical Development

Subtype Specification

Adult Neurogenesis

Expression Patterns

Brain Regional Distribution

Temporal Expression

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Neurodevelopmental Disorders

Therapeutic Applications

Stem Cell Programming

Direct Conversion

Disease Modeling

Interaction Network

Protein Interactions

Signaling Pathways

Animal Models

Knockout Phenotype

Transgenic Models

Research Methods

Detection Techniques

Model Systems

Unanswered Questions

NGN2 in Neurodegenerative Disease

Alzheimer's Disease

Cholinergic System Impact

Neurogenesis Alterations

Parkinson's Disease

Dopaminergic Differentiation Protocol

Disease Modeling Applications

Neurodevelopmental Disorders

Molecular Mechanisms

Direct Reprogramming Applications

Astrocyte-to-Neuron Conversion

In Vivo Reprogramming

Fibroblast Direct Conversion

Therapeutic Potential

Cell Replacement Therapy

Drug Discovery Platform

Gene Therapy Approaches

Molecular Interactions

Epigenetic Regulation

Non-coding RNA Control

Comparative Biology

Species Conservation

Evolutionary Insights

Cross-Links

External Links

References

See Also

Pathway Diagram

💬 Discussion